Pediatric Hematology And Oncology

杂志介绍

Pediatric Hematology And Oncology杂志介绍

《Pediatric Hematology And Oncology》是一本以English为主的未开放获取国际优秀期刊，中文名称儿科血液学和肿瘤学，本刊主要出版、报道医学-HEMATOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为1.2，最新CiteScore 指数为2.6。

本刊近期中国学者发表的论文主要有：

• Clinical features and prognostic implications of ecotropic viral integration site 1 (EVI1) in childhood acute lymphoblastic leukemia

  Author: Jia, Ming; Hu, Bo-Fei; Zhang, Jing-Ying; Xu, Li-Yao; Tang, Yong-Min

• Specific cytokine patterns in Epstein-Barr virusassociated hemophagocytic lymphohistiocytosis compared to Kawasaki disease in children

  Author: Yang, Yanli; Yu, Hanqing; Li, Chenli; Gui, Zhen; Chang, Yong

• Outcome of children with Langerhans cell histiocytosis and single-system involvement: A retrospective study at a single center in Shanghai, China.

  Author: Su M¹, Gao YJ¹, Pan C¹, Chen J¹, Tang JY¹.

• Fetal-onset congenital dyserythropoietic anemia type 1 due to CDAN1 mutations presenting as hydrops fetalis.

  Author: Liu S¹, Liu YN², Zhen L³, Li DZ³.

英文介绍

Pediatric Hematology And Oncology杂志英文介绍

PHO: Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Our goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians and scientists who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal supports articles that address research in diverse clinical settings, exceptional case studies/series that add novel insights into pathogenesis and/or clinical care, and reviews highlighting discoveries and challenges emerging from consortia and conferences. Clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies and transplantation are of interest. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from scientists and clinicians across the international community of Pediatric Hematology and Oncology are considered for publication. The journal is not dependent on or connected with any organization or society. All submissions undergo rigorous peer review prior to publication. Our Editorial Board includes experts in Pediatric Hematology and Oncology representing a wide range of academic and geographic diversity.